Cell line | Treatment | ||||
---|---|---|---|---|---|
 | Control | CSE (1.0%) | CSE (2.5%) | CSE (5.0%) | TNF-α (10 ng/ml) |
 | Interleukin-8 (IL-8) pg/ml | ||||
Human lung cancer cells (H1299) | 51.3 ± 3.2 | 53.7 ± 4.7 | 56.5 ± 7.4 | 45.1 ± 3.1 | 432 ± 59.1*** |
Human adenocarcinoma cells (A549) | 623 ± 52.9 | 635 ± 52.4 | 620 ± 80.1 | 612 ± 76.3 | 1200 ± 100*** |
Human papillary adenocarcinoma cells (H441) | 200 ± 27.2 | 210 ± 35.1 | 200 ± 58.4 | 198 ± 39.2 | 384 ± 28.1*** |
 | Interleukin-6 (IL-6) pg/ml | ||||
Rat lung epithelial cells (L2) | 40.2 ± 4.8 | 43.1 ± 5.2 | 41.5 ± 7.2 | 38.8 ± 2.6 | 165 ± 14.5*** |
Murine type II epithelial cells (MLE-15) | 35.6 ± 2.3 | 31.4 ± 5.5 | 38.1 ± 2.3 | 31.9 ± 3.6 | 74.5 ± 5.7*** |